These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39389734)

  • 61. Reperfusion correlates and clinical outcomes of right ventricular dysfunction in patients with inferior ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Piccolo R; Niglio T; Spinelli L; Capuano E; Strisciuglio T; D'Anna C; De Luca S; Leosco D; Rapacciuolo A; Cirillo P; Stabile E; Esposito G; Trimarco B; Piscione F; Galasso G
    Am J Cardiol; 2014 Jul; 114(2):243-9. PubMed ID: 24952928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.
    Gong X; Zhou L; Ding X; Chen H; Li H
    BMC Cardiovasc Disord; 2021 Apr; 21(1):182. PubMed ID: 33858349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Right ventricular dysfunction in stress cardiomyopathy: The prognostic value of fractional area change.
    Subramanian M; Ahamed H; Reddy C; Mathew N; Chandrasekhar R
    Echocardiography; 2020 Sep; 37(9):1366-1373. PubMed ID: 32815596
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Flaherty MP; Moses JW; Westenfeld R; Palacios I; O'Neill WW; Schreiber TL; Lim MJ; Kaki A; Ghiu I; Mehran R
    Catheter Cardiovasc Interv; 2020 May; 95(6):1111-1121. PubMed ID: 31355987
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Right ventricular dysfunction in children supported with pulsatile ventricular assist devices.
    Karimova A; Pockett CR; Lasuen N; Dedieu N; Rutledge J; Fenton M; Vanderpluym C; Rebeyka IM; Dominguez TE; Buchholz H
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1691-1697.e1. PubMed ID: 24342898
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
    Obokata M; Reddy YNV; Melenovsky V; Pislaru S; Borlaug BA
    Eur Heart J; 2019 Feb; 40(8):689-697. PubMed ID: 30544228
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic Value of Right Ventricular Function Assessed by Echocardiography in Patients Presenting With a First Acute ST Elevation Myocardial Infarction Treated By Primary PCI.
    Zamfir D; Pitic D; Tamaşescu G; Onciul S; Tăutu O; Angelescu C; Onuţ R; Stoian M; Dorobanţu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):824-33. PubMed ID: 30137954
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of right ventricular dysfunction in patients presenting with acute left-sided heart failure.
    Shaker MM; Taha HS; Kandil HI; Kamal HM; Mahrous HA; Elamragy AA
    Egypt Heart J; 2024 Jan; 76(1):2. PubMed ID: 38165525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella.
    Basir MB; Bentley D; Truesdell AG; Kunkel K; Lemor A; Megaly M; Alqarqaz M; Alaswad K; Khandewal A; Jortberg E; Kalra S; Kaki A; Burkhoff D; Moses JW; Pinto DS; Stone GW; O'Neill WW
    J Card Fail; 2024 Oct; 30(10):1287-1299. PubMed ID: 39389740
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
    Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW
    J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of right ventricular dysfunction on the outcome of heart failure patients undergoing surgical ventricular reconstruction†.
    Garatti A; Castelvecchio S; Di Mauro M; Bandera F; Guazzi M; Menicanti L
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):333-40; discussion 340. PubMed ID: 24755103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early effect of left coronary system revascularization on right ventricular mechanics in patients with right coronary artery chronic total occlusion.
    Acar G; Aksakal A; Ozkan B; Alici G; Alizade E; Bulut M; Yazicioğlu MV; Tanboğa IH; Akçakoyun M; Esen AM
    Acta Cardiol; 2012 Dec; 67(6):707-12. PubMed ID: 23393942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem.
    Kavarana MN; Pessin-Minsley MS; Urtecho J; Catanese KA; Flannery M; Oz MC; Naka Y
    Ann Thorac Surg; 2002 Mar; 73(3):745-50. PubMed ID: 11899176
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass grafting or protected percutaneous coronary intervention with the Impella 2.5 device.
    Becher T; Baumann S; Eder F; Perschka S; Loßnitzer D; Fastner C; Behnes M; Doesch C; Borggrefe M; Akin I
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):360-368. PubMed ID: 28660768
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Short-term prognostic value of TAPSE, RVFAC and Tricuspid S' wave peak systolic velocity after first acute myocardial infarction.
    Awad EML; Mahmoud AH; Maghrby KS; Taha NM; Ibrahim AM
    BMC Res Notes; 2020 Apr; 13(1):196. PubMed ID: 32238188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.